Table. All-Cause Mortality in the Individual Trials.
| Source (Trial Name) | Follow-up, moa | All-Cause Mortality, No. With End Point/Total No. | |
|---|---|---|---|
| ICD Group | Control Group | ||
| Bänsch et al, 2002 (CAT) | 66.0 (26.4) | 13/50 | 17/54 |
| Kadish et al, 2004 (DEFINITE) | 29.0 (14.4) | 28/229 | 40/229 |
| Bardy et al, 2005 (SCD-HeFT) | 45.5 (34.8-55.2) | 71/424 | 95/417 |
| Køber et al, 2016 (DANISH) | 67.6 (49.0-85.0) | 58/234 | 65/237 |
| All | NA | 170/937 | 217/937 |
Abbreviations: CAT, Cardiomyopathy Trial; DANISH, Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality; DEFINITE, Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation; ICD, implantable cardioverter defibrillator; NA, not applicable; SCD-HeFT, Sudden Cardiac Death in Heart Failure Trial.
a
Presented as mean (SD) in the CAT and DEFINITE trials and median (interquartile range) in the SCD-HeFT and DANISH trials.